Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-03-25
2008-03-25
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S341000, C514S369000, C514S376000, C514S378000, C514S406000, C546S257000, C546S275400, C548S186000, C548S232000, C548S243000, C548S365700, C548S377100
Reexamination Certificate
active
10509894
ABSTRACT:
We describe substituted benzenesulfoximine compounds having anti-inflammatory activity, processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of inflammatory diseases.
REFERENCES:
patent: 5633272 (1997-05-01), Talley
patent: 5859257 (1999-01-01), Talley
patent: 5981576 (1999-11-01), Belley
patent: 5985902 (1999-11-01), Talley
patent: 6020343 (2000-02-01), Belley
patent: 6169188 (2001-01-01), Belley
patent: 6673818 (2004-01-01), Brown
patent: 6699884 (2004-03-01), Brown
patent: 2003/0032657 (2003-02-01), Brown et al.
patent: 2003/0114456 (2003-06-01), Rosales
patent: 2003/0149078 (2003-08-01), Brown et al.
patent: 3522230 (1987-01-01), None
patent: 1251126 (2002-10-01), None
patent: 1251126 (2002-10-01), None
patent: 01/83475 (2001-11-01), None
patent: 03/087062 (2003-10-01), None
patent: 03/087062 (2003-11-01), None
Indicates that CAS Abstract and Structure Findings are attached.
Morissette et al. Advanced Drug Delivery Reviews 2004, 56, 275-300.
International Search Report.
Puig et al. “Synthesis and biological evaluation of 3,4-diaryloxazolones: A new class of orally active cyclooxygenase-2 inhibitors” Journal of Medicinal Chemistry, vol. 43, No. 2, pp. 214-223 (2000).
Penning et al. “Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib)” Journal of Medicinal Chemistry, vol. 40, No. 9, pp. 1347-1365 (1997).
Shin et al. “2,2-Dimethyl-4,5-diaryl-3(2H)furanone derivatives as selective cyclo-oxygenase-2 inhibitors” Bioorganic & Medicinal Chemistry Letters, vol. 11, No. 2, pp. 165-168 (2001).
Friesen et al. “2-Pyrindinyl-3-(4-methylsulfonyl)phenylpyridines: Selective and orally active cyclooxygenase-2 inhibitors” Bioorganic & Medicinal Chemistry Letters, vol. 8, No. 19, pp. 2777-2782 (1998).
Jain Mukul R.
Lohray Braj B.
Lohray Vidya B.
Patel Gautam D.
Pingali Harikishore
Anderson Rebecca
Cadila Healthcare Limited
Nixon & Vanderhye P.C.
Nolan Jason M
LandOfFree
Heterocyclic compounds process for their preparation and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compounds process for their preparation and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds process for their preparation and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3950239